A pilot study of the effect of spironolactone therapy on exercise capacity and endothelial dysfunction in pulmonary arterial hypertension: study protocol for a randomized controlled trial-Reference-Cited by-同舟云学术

A pilot study of the effect of spironolactone therapy on exercise capacity and endothelial dysfunction in pulmonary arterial hypertension: study protocol for a randomized controlled trial

Published:2013 Issue:1 Volume:14 Page:91
ISSN:1745-6215
Container-title:Trials
language:en
Short-container-title:Trials

Author:

Elinoff Jason M,Rame J,Forfia Paul R,Hall Mary K,Sun Junfeng,Gharib Ahmed M,Abd-Elmoniem Khaled,Graninger Grace,Harper Bonnie,Danner Robert L,Solomon Michael A

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Medicine (miscellaneous)

Reference56 articles.

1. Pulmonary Arterial Hypertension

2. Survival in Patients with Primary Pulmonary Hypertension

3. Survival in Primary Pulmonary Hypertension with Long-Term Continuous Intravenous Prostacyclin

4. Endothelial Dysfunction in Pulmonary Hypertension

5. Endothelial Dysfunction in Pulmonary Hypertension

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Firefighter uncompensable heat stress results in excessive upper body temperatures measured by infrared thermography: Implications for cooling strategies;Applied Ergonomics;2024-10

2. Dysregulation of the Long Noncoding RNA X-Inactive–Specific Transcript Expression in Male Patients with Pulmonary Arterial Hypertension;The American Journal of Pathology;2024-08

3. Emerging vascular cell-specific roles for mineralocorticoid receptor: implications for understanding sex differences in cardiovascular disease;American Journal of Physiology-Cell Physiology;2023-01-01

4. Mineralocorticoid receptor antagonist treatment of established pulmonary arterial hypertension improves interventricular dependence in the SU5416-hypoxia rat model;American Journal of Physiology-Lung Cellular and Molecular Physiology;2022-03-01

5. Signal Transduction during Metabolic and Inflammatory Reprogramming in Pulmonary Vascular Remodeling;International Journal of Molecular Sciences;2022-02-22